GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)

$636,578
Ana Aparicio · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA

A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies

$636,517
Paul E Kinahan · University Of Washington · U24 · FY2025 · CA

A Statistical Physics Framework for Understanding the Role of Repeat RNA in Tumor Immunity

$636,517
Benjamin Greenbaum · Sloan-Kettering Inst Can Research · U01 · FY2022 · CA

A Statistical Physics Framework for Understanding the Role of Repeat RNA in Tumor Immunity

$636,517
Benjamin Greenbaum · Sloan-Kettering Inst Can Research · U01 · FY2023 · CA

Enhancing cell therapy for brain tumors

$636,455
Catherine Mary Bollard · Children'S Research Institute · U01 · FY2021 · CA

Targeting STAT3 to enhance anti-tumor immunity

$636,402
Daniel E Johnson · University Of California, San Francisco · R01 · FY2020 · DE

Targeting STAT3 to enhance anti-tumor immunity

$636,402
Daniel E Johnson · University Of California, San Francisco · R01 · FY2023 · DE

Targeting STAT3 to enhance anti-tumor immunity

$636,402
Daniel E Johnson · University Of California, San Francisco · R01 · FY2021 · DE

Image-guided cancer therapy using heat activatable CAR T cells

$636,385
Stanislav Y Emelianov · Georgia Institute Of Technology · R01 · FY2025 · EB

Non-canonical Wnt-Receptor Signaling and Targeted Therapies

$636,298
Thomas J. Kipps · University Of California, San Diego · R01 · FY2020 · CA

Lineage Addiction in Prostate Cancer: Molecular Interactions and Translational Biomarkers

$636,167
Joshua Michael Lang · University Of Wisconsin-Madison · P01 · FY2025 · CA

Predicting Prostate Cancer Aggressiveness

$636,055
Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2011 · CA

Mechanisms of Tumor Cell Dormancy and Tumor Recurrence

$636,013
Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Cancer stem cells and human liver cancer

$635,990
Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma

$635,966
Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA

A precision oncology approach to integrating of tumor microenvironment suppressive cell modulators to enhance antitumor immunity

$635,965
Dung T Le · Johns Hopkins University · P01 · FY2024 · CA

Lung leukocytes promote alveolar epithelial regeneration after severe injury

$635,891
Nicholas Arpaia · Columbia University Health Sciences · R01 · FY2020 · HL

Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer

$635,854
Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA

TMEM, MENAcalc, and MENAINV as Prognostic and Predictive Markers for Breast Cancer Metastasis

$635,845
Thomas E Rohan · Albert Einstein College Of Medicine · R01 · FY2024 · CA

"Charting cellular attraction-based interactome with Multivalent Adhesive Probe AFM (MAPA)"

$635,749
Pawel A. Osmulski · University Of Texas Hlth Science Center · R61 · FY2025 · CA

PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS; TASK ORDER: PREVENTION OF COLORECTAL CANCER WITH IPSC-

$635,712
Powel Brown · University Of Tx Md Anderson Can Ctr · N01 · FY2021 · CA

Overcoming the immune-suppressive tumor microenvironment through in situ vaccination nanotechnology.

$635,587
Nicole Franziska Steinmetz · University Of California, San Diego · U01 · FY2018 · CA

Immunobiology and immunotherapy of pancreatic cancer

$635,533
Robert H Vonderheide · University Of Pennsylvania · R01 · FY2015 · CA

AMPLIFICATION EVENTS ALTERING TUMOR MICROENVIRONMENT THAT DRIVE METASTASIS IN HER2+ BREAST CANCER

$635,304
Michigan State University · · FY2021 · Defense Health Agency

A model for predicting response to PD-1 inhibitors in NSCLC

$635,258
Edward B Garon · University Of California Los Angeles · R01 · FY2018 · CA